XENE ▼ -25.4% - Xenon Pharmaceuticals Inc.
$XENE d/g Hold # DB pt 46
Xenon Pharmaceuticals fell 25.4% today following a downgrade to Hold and a price target of $46 from Deutsche Bank, suggesting analyst reassessment of the stock's near-term prospects.
18-SEP-2026 05:20 AM ET
Share this post
More filings for $XENE
XENE - Xenon Pharmaceuticals Inc. - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 16, 2026XENE ▲ +2.0% - Xenon Pharmaceuticals Inc.Nov 9, 2026XENE - Xenon Pharmaceuticals Inc. - SEC Filing Update (06-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 6, 2026XENE - Xenon Pharmaceuticals Inc. - SEC Filing Update (05-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 5, 2026XENE ▲ +1.6% - Xenon Pharmaceuticals Inc.Nov 3, 2026XENE ▲ +0.5% - Xenon Pharmaceuticals Inc.Nov 2, 2026
View full $XENE filing history →💬 Comments
Loading comments…
Leave a comment
